NIOX Group Company Description

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients.

The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.

NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

NIOX Group Plc

Country	United Kingdom
Founded	2006
Industry	Medical Devices
Sector	Healthcare
Employees	91
CEO	Jonathan Emms

Contact Details

Address: Magdalen Centre Oxford, OX4 4GA United Kingdom
Phone	44 3303 309 356
Website	investors.niox.com

Stock Details

Ticker Symbol	CSSPF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BJVD3B28
SIC Code	2836

Key Executives

Name	Position
Jonathan Emms	Chief Executive Officer and Executive Director
Ian Roy Johnson	Executive Chairman
Michael Roy David Roller A.C.A., BA (Hons)	Chief Financial Officer and Director
Tom Scaccia	Senior Vice President of Americas and Research Business
Sarah Elizabeth Duncan	Group Financial Controller and Company Secretary